Consumers have become “omni-shoppers,” quickly shifting from physical and digital channels interchangeably, moving between retailers to get what they want, when they want it. This means retailers must now provide an exceptional customer exp…
Details: Breaking down the potential global economic and market impacts The Russian invasion of Ukraine marks the beginning of a new era of geopolitical conflict. For the global economy that has not fully healed from the hardships of the pa…
Roper St. Francis Healthcare (RSFH) is the Lowcountry’s only private, not-for-profit healthcare system. RSFH partnered with DocASAP to create a convenient retail experience for their physician network through online appointment scheduling. …
Roper St. Francis Healthcare (RSFH) is the Lowcountry’s only private, not-for-profit healthcare system. RSFH partnered with DocASAP to create a convenient retail experience for their physician network through online appointment scheduling. …
Today’s clinical trials require sponsors to adapt and pivot faster. To do so, sponsors need to access and leverage clinical trial operational performance data assets to design a study, optimize its feasibility, and monitor its performance. They also ne…
Today’s clinical trials require sponsors to adapt and pivot faster. To do so, sponsors need to access and leverage clinical trial operational performance data assets to design a study, optimize its feasibility, and monitor its performance. They also ne…
In an environment where patient centricity and value demonstration are becoming a greater focus for stakeholders across the healthcare spectrum, the need to understand the 360 degree view of the patient, together with improvements in measuring patient …
In an environment where patient centricity and value demonstration are becoming a greater focus for stakeholders across the healthcare spectrum, the need to understand the 360 degree view of the patient, together with improvements in measuring patient …
Disruptions preventing or limiting clinical trial site access to patients, monitors, and CRAs have propelled long-lasting changes in the research industry, supported by the adoption of trial decentralization technologies. The urgency to adapt to evolvi…
Disruptions preventing or limiting clinical trial site access to patients, monitors, and CRAs have propelled long-lasting changes in the research industry, supported by the adoption of trial decentralization technologies. The urgency to adapt to evolvi…
